The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has issued an addendum to its ...

Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for ...

A desperate young man kidnaps a wealthy pharmaceutical executive believing that she’s an alien sent to enslave the people of ...

RIYADH, Saudi Arabia — Like Donald Trump, Crown Prince Mohammed bin Salman understands the power of personal branding. So you ...

A solid clinical win for a promising candidate helped jolt the stock a few months ago. And just last week, the company's latest quarterly update provided yet another boost. Here is why Eli Lilly is a ...

Mark Hartley is looking forward to a great month leading into the festive season, with two of his top FTSE 100 stocks already ...

Mercado Livre’s move into Brazil’s pharma retail sector tests the hegemony in a sector guarded by laws and norms ...

Amgen today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful reductions in ...

The pledge also is a sign of the areas where Bill Gates wants to focus on as he seeks to donate the vast majority of his $114 ...

In recent days, Regeneron Pharmaceuticals announced detailed positive Phase 2 trial results for two novel factor XI ...

Patients have options beyond statins, and other alternatives are on the horizon.

For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications may not be sufficient in helping them reach their target cholesterol levels.